NWAM LLC’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
CI
FCBT
NWAM LLC's XPH Position: Q4 2023 in Review
NWAM LLC sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2023, closing a stake of 5,564 shares — an estimated $221K sold.
NWAM LLC first reported a position in XPH in Q3 2018 and held it in 18 quarters. The position peaked at $856K in Q4 2020. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2023.
- NWAM LLC reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2023 after selling out during the quarter.
- NWAM LLC sold 5,564 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2023, an estimated $221K.
- NWAM LLC first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2018 and held it in 18 quarters.
- NWAM LLC's State Street SPDR S&P Pharmaceuticals ETF position peaked at $856K in Q4 2020.
- 73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2023.
Based on NWAM LLC's 13F filing for Q4 2023, filed 14 Feb 2024.